Ghost Tree Capital’s Sio Gene Therapies SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-12,500
Closed -$688K – 78
2017
Q3
$688K Sell
12,500
-9,375
-43% -$1.58M 0.15% 62
2017
Q2
$4.06M Buy
+21,875
New +$3.83M 0.84% 44
2016
Q4
– Sell
-50,000
Closed -$5.6M – 99
2016
Q3
$5.6M Sell
50,000
-21,875
-30% -$2.63M 0.91% 38
2016
Q2
$7.38M Buy
+71,875
New +$7.18M 2.13% 15
2015
Q3
– Sell
-16,875
Closed -$2.75M – 99
2015
Q2
$2.75M Buy
+16,875
New +$2.86M 0.89% 46

Other funds holding SIOX

Ghost Tree Capital's SIOX Position: Q4 2017 in Review

Ghost Tree Capital sold out of Sio Gene Therapies (SIOX) in Q4 2017, closing a stake of 12,500 shares — an estimated $688K sold.

Ghost Tree Capital first reported a position in SIOX in Q2 2015 and held it in 5 quarters. The position peaked at $7.38M in Q2 2016. 105 funds tracked by Wall St. Rank hold SIOX as of Q4 2017.

  • Ghost Tree Capital reported no remaining Sio Gene Therapies position as of Q4 2017 after selling out during the quarter.
  • Ghost Tree Capital sold 12,500 Sio Gene Therapies shares in Q4 2017, an estimated $688K.
  • Ghost Tree Capital first reported a position in Sio Gene Therapies in Q2 2015 and held it in 5 quarters.
  • Ghost Tree Capital's Sio Gene Therapies position peaked at $7.38M in Q2 2016.
  • 105 funds tracked by Wall St. Rank held Sio Gene Therapies as of Q4 2017.

Based on Ghost Tree Capital's 13F filing for Q4 2017, filed 14 Feb 2018.